January 11, 2019 07:41 AM EST

Anti-aging startup Elevian enlists Insilico on AI quest for 'young blood'

Amber Tong

Some of the earliest connections Alex Zhavoronkov has built for his AI shop at Insilico Medicine involves marrying anti-aging and AI research, two of the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Anti-aging startup Elevian enlists Insilico on AI quest for 'young blood'

Amber Tong

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Merck pays $30M to buy ‘chameleon’ approach to deadly brain cancers

Eye drop maker to merge with a retinal gene therapy startup from Spark co-founder

UK’s price watchdog says Lilly’s Alzheimer’s drug is too costly for broad uptake

Corrected: Sangamo to seek accelerated approval for Fabry gene therapy, claims it won't need confirmatory study

Amgen preps to launch Eylea biosimilar years early after Regeneron loses appeal

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

An­ti-ag­ing start­up Ele­vian en­lists In­sil­i­co on AI quest for 'y­oung blood'

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Anti-aging startup Elevian enlists Insilico on AI quest for 'young blood'